Biocontrol potential and genomic analysis of novel lytic bacteriophage CABI-SEA 2302 against multidrug-resistant avian pathogenic Escherichia coli associated with colibacillosis
Rattachement africain : th. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Multidrug-resistant avian pathogenic Escherichia coli (MDR-APEC) causes critically high first-week mortality in chickens, resulting in substantial economic losses in the global poultry industry. This study aimed to isolate and characterize a novel bacteriophage as an effective safe alternative for the control of colibacillosis. A lytic bacteriophage CABI-SEA 2302 was obtained from E. coli lesion samples collected from commercial poultry farms. The selected phage was classified as a new species in the genus Tunavirus, subfamily Tunavirinae. Genomic analysis revealed that the phage contains 49,550 base pairs of double-stranded DNA genome with 55% GC content, no toxin, virulence, and antimicrobial resistance genes. Phage CABI-SEA 2302 exhibited lytic activity against 24% of MDR-APEC clinical isolates (12/50) obtained from broiler and layer chicken lesions. An adsorption rate of 87% to the bacterial host was observed within 10 min. One-step growth analysis showed that phage CABI-SEA 2302 had a latent period of 20 min and a burst size of 458 PFU/cell. At the lowest multiplicity of infection of 0.001, a representative MDR-APEC isolate was significantly reduced at 3 h post-infection. Cellular abnormality of the MDR-APEC isolate exposed to the novel phage was confirmed by scanning electron microscopy. More importantly, phage CABI-SEA demonstrated potent inhibition of bacterial biofilm formation. Notably, the phage survived under simulated chicken gastrointestinal conditions (99.00 ± 3.61%) and remained stable at temperatures between -80-60 °C and pH 2-12. By specifically targeting bacterial host cells and inhibiting biofilms, this approach could reduce the reliance on traditional antibiotics in the commercial poultry industries.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Biocontrol potential and genomic analysis of novel lytic bacteriophage CABI-SEA 2302 against multidrug-resistant avian pathogenic Escherichia coli associated with colibacillosis
- Date Crossref
- 01/12/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Prince of Songkla University pays non établi dans la noticeUniversité ou école supérieure
-
Faculty of Science Division of Biological Science pays non établi dans la noticeUniversité ou école supérieure
-
Faculty of Veterinary Science pays non établi dans la noticeUniversité ou école supérieure
Prince of Songkla University, Division of Biological Science — Faculty of Science et Faculty of Veterinary Science.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.